Schlagwort: ‘Information System’
Shanxi: Electronic first transaction information of drugs will be recognized
On April 26th, Shanxi Food and Drug Administersration issued the “Implementation Opinion of promoting the transformation and upgrading of pharmaceutical enterprises (consultation paper).” The “Implementation Opinion” clarified that pharmaceutical enterprises are encouraged to implement electronic management of the first transaction information of drugs under the premise of the quality, safety, and traceability. The Drug and Food Administration recognizesd the electronic first transaction information during the certification and inspection that obey the “Good Supply Practice for Pharmaceutical Products.”
山西药监局明确检查时认可电子首营
来源：新浪医药新闻 2019.04.29
核心提示：4月26日，山西省药品监督管理局发布《关于推动药品流通企业转型升级创意发展的实施意见（征求意见稿）》（下文简称《意见稿》）。《意见稿》明确，鼓励药品经营企业开展药品经营业务时，在确保药品质量安全、可追溯的前提下实行首营品种档案电子化管理。药品监管部门在实施《药品经营质量管理规范》认证检查时对电子首营资料予以认可。
Jilin Province issued 39 measures to promoting the medical reform
Recently, the General Office of the Jilin Provincial Government published the “Notification on the major tasks of Deepening the Reform of Medical and Health System in Jilin Province in 2019” and proposed 39 measures to accelerate the establishment of a quality and efficient medical and health service system. The “Notification” clarifies that a Regional Medical Service Capability Improvement Program should be implemented. The establishment of the medical association, a long-distance medical treatment platform, and a universal coverage health information system should be promoted in the whole province.
吉林39项措施助推医改
来源：健康报 2019.04.27
近日，吉林省政府办公厅印发《吉林省深化医药卫生体制改革2019年重点工作任务的通知》，提出39项措施加快建立优质高效的医疗卫生服务体系。《通知》明确，应启动实施吉林省区域医疗服务能力提升计划；全省范围推进医联体、远程医疗会诊平台和全民健康信息系统的建设。
Guangzhou: a implementation opinion on promoting the application of health and medical big data is released
Recently, the Guangzhou General Office of the People’s Government published “The Implementation Opinion on promoting the Application of Health and Medical Big Data”. The “Opinion” proposed to improve the medical data collection mechanisms and establish a catalog of health and medical data resources in the city to realize the sharing of data resources across departments and regions. It stipulates to develop the application of health and medical big data in order to provide a whole process of online medical services for citizens. A unified drug prescription circulation platform should be established so as to realize information interconnection between hospitals, pharmacies, and delivery companies.
广州印发推进健康医疗大数据应用实施意见
来源：医药网 2019.01.04
核心提示：近日，广州市政府办公厅印发了《关于推进健康医疗大数据应用的实施意见》（下称《意见》）。《意见》提出，健全医疗数据采集机制，建立全市健康医疗数据资源目录，实现数据资源跨部门、跨区域共享；发展健康医疗大数据应用，为市民提供全流程在线诊疗服务；建立统一的药品处方流转平台，实现医院、处方流转平台、药店和配送系统的信息互联互通。
A supplementary document for procurement of drugs is released(“4+7”)
On December 27th, the State Food and Drug Administration issued the “Notification on reinforcing drug supervision during the pilot of centralized procurement and use of selected drugs.” The “Notification” stipulated that each provincial drug regulatory authority should reinforce the quality supervision of the production, circulation, and use of selected drugs and the punishment for enterprises that violatie laws and regulations. The regulation authority should also urge the selected enterprises to establish a reporting system for inventory and off-production. The “Notification” indicates that the drug distribution should be regulated through related treaties to ensure the drug supply.
国家药监局发布4+7配套文件， 确保中标药品质量安全
来源：制药站 2018.12.28
核心提示：12月27日，国家药监局发布《国家药监局关于加强药品集中采购和使用试点期间药品监管工作的通知》（以下简称《通知》）。《通知》要求，各省级药品监管部门应加大对中标药品生产、流通、使用全周期的质量监管，加大违法违规企业的处罚力度，要督促中标生产企业建立企业库存和停产报告制度。《通知》指出，应通过协议规范配送行为，以保证药品供应。
Fujian encourages the implementation of electronic first transaction information of drugs
On October 10th, Fujian Food and Drug Administration published “Notification on encouraging drug production and management enterprises to implement electronic first transaction information of drugs”. The “Notification” indicates that pharmaceutical enterprises and medical institutes are encouraged to use the Internet to establish a drug traceability system and an electronic exchange platform for the first transaction information. The “Notification” also stipulates that the platform should comply with the relevant national laws and regulations, and undertake the corresponding legal responsibility.
福建鼓励实施药品首营资料电子化
来源：中国医药报 2018.10.12
核心提示：10月10日，福建省食品药品监管局印发《关于鼓励药品生产经营企业实施药品首营资料电子化的通知》（以下简称《通知》）。《通知》指出，鼓励药企及医疗机构运用互联网建立药品追溯体系和首营资料电子化交换平台。《通知》要求，平台应符合国家相关法律法规规定，并承担相应的法律责任。
Opinions of the national basic medical system would be released
On September 19th, 2018, the State Council published “Guiding opinions on the improvement of the national basic medical system.” The “Guiding opinions” stipulates the establishment of a wholesome drug use monitoring platform and monitoring network system.It persists in centralized drug procurement, implements drug classification and acquisition; encourages local areas to combine basic drug system with classified medical treatment, family doctor contracting services and chronic disease health management so as to reduce the financial burden of patients. It establishes a wholesome national shortage of drug monitoring and early warning system, by the way of a reasonable purchase price, fixed-point production and unified distribution to ensure drug supply.
国家基本医药制度意见出台
来源：中国制药网 2018.09.19
核心提示：9月19日，国务院印发《关于完善国家基本医药制度的意见》。《意见》要求，建立健全的药品使用监测平台以及监测网络体系；坚持药品集中采购，落实药品分类采购；鼓励地方将基本药物制度与分级诊疗、家庭医生签约服务、慢性病健康管理结合，降低患者负担；建立健全的全国短缺药品监测预警系统，确定合理采购价格、定点生产、统一配送以保证药品供应。
The electronic drug regulation will be recommissioned
On August 24th, 2018, the State Food and Drug Administration issued “Guiding Opinions on the Construction of a Drug Information and Traceability System (consultation paper)”. The “Guiding Opinion” stipulates that licensed sellers of drugs and pharmaceutical enterprises should each establish their own traceability system. The ownership of the drug traceability data is determined by the principle “who generated, who owns”. It encourages Holders, pharmaceutical enterprises, users, industry associations, third-party service agencies, and administrative departments to implement the interconnection of drug information traceability through the drug traceability collaborative service platform.
国家药监局: 重启药品电子监管
来源：医药网 2018.08.27
核心提示：8月24日，国家药监局发布《关于药品信息化追溯体系建设的指导意见（征求意见稿）》（下称《意见》）。意见要求，药品上市许可持有人和药企应自建追溯系统；药品追溯数据的所有权为“谁产生、谁所有”；鼓励持有人、药企、使用单位、行业协会、第三方服务机构、行政管理部门通过药品追溯协同服务平台实现药品信息化追溯各方互联互通。
Anhui establishes a Drug Quality and Security Traceability System for pharmaceutical enterprises
Recently, the Anhui Food and Drug Administration issued the “Guiding Opinions on the Construction of Drug Quality and Safety Traceability System for Pharmaceutical Enterprises in Anhui Province.” The “Guiding Opinions” clarify that pharmaceutical enterprises all over the province should establish a drug traceability system in accordance with laws and regulations. The traced information content of all links of the drug business should be true, accurate and complete, and should be saved at least for five years. For those who have not yet established a traceability system and for those traceability systems who do not operate effectively, especially when included incorrect information or incomplete information, it will be seriously investigated and dealt with following relevant laws and regulations.
安徽部署建立药品经营企业质量安全追溯体系
来源：中国医药报 2018.08.03
核心提示：日前，安徽省食品药品监管局印发《安徽省药品经营企业药品质量安全追溯体系建设指导意见》（以下简称《意见》）。《意见》明确，全省药品经营企业应按照法律法规建立药品追溯制度，药品经营各环节追溯信息内容应真实、准确、完整，且至少保存五年。对于没有建立追溯体系、追溯体系不能有效运行，特别是出现不真实信息或信息丢失的，将依照相关法律法规严肃查处。
Anhui: The 2018 version of the medical insurance catalog is released
Recently, Anhui Human Resources and Social Security issued the “Medicine Catalogue of Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance in Anhui Province(2018 version)”, which will be implemented from July, 1st, 2018. The catalog includes 1481 western medicines and 1356 Chinese patent medicines. Anhui Human Resources and Social Security indicates that Anhui Province will use the unified “Drug Catalog” database. The drugs on the catalog will be coded according to the “Social Insurance Drug Classification Code”, which will be confirmed by the provincial medical insurance administrative department.
安徽：2018版医保目录出炉
来源：中国医药报 2018.05.29
核心提示：日前，安徽省人社厅发布《安徽省基本医疗保险、工伤保险和生育保险药品目录2018年版》，将于7月1日起执行。该目录包括西药1481个，中成药1356个。安徽省人社厅表示，安徽省将使用统一的《药品目录》数据库，并按照《社会保险药品分类代码》对目录药品进行对码，由省级医保行政部门进行确认。
Jiangxi: electronic patient record may be shared within hospitals
In July 2017, the Jiangxi province published the development plan of health information for the 13th Five Year. The plan clearly highlighted the big data industry for healthcare. Until 2020, a health information platform should be created at the level of provinces, cities and countries; databases of population information, electronic health documents and patient records within the province should be created, so that the health big data center for Jiangxi can be built. (Source: Jiangnan City News)
江西：医院之间将可共享电子病历
来源：江南都市报 2017-07-27
核心提示：江西省近日出台《江西省“十三五”全民健康信息化发展规划》，明确提出将培育健康医疗大数据产业。到2020年，建成省、市、县三级全民健康信息平台，完成全省人口信息、电子健康档案和电子病历三大数据库的建设，初步建成健康江西全民健康大数据中心。